Tolmetin

Details About Generic Salt ::  Tolmetin

Main Medicine Class:: Analgesic,NSAID   

(TOLE-mee-tin SO-dee-uhm)
Tolectin 200, Tolectin 600, Tolectin DS,  Novo-Tolemtin
Class: Analgesic/NSAID

 

Drugs Class ::

 Action Decreases inflammation, pain and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.

Indications for Drugs ::

 Indications Treatment of chronic and acute rheumatoid arthritis and osteoarthritis and juvenile rheumatoid arthritis.

Drug Dose ::

 Route/Dosage

Osteoarthritis/Rheumatoid Arthritis

ADULTS: PO 400 mg tid initially; titrate to 600 to 1600 mg/day for osteoarthritic patients or 600 to 1800 mg/day in divided doses for rheumatoid arthritis patients. Daily doses exceeding 1800 mg/day are not recommended.

Juvenile Rheumatoid Arthritis

CHILDREN ³ 2 YR: PO 20 mg/kg/day in 3–4 divided doses initially; titrate to 15–30 mg/kg/day (aximum 30 mg/kg/day).

Contraindication ::

 Contraindications Hypersensitivity to aspirin, iodides or any NSAID.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children < 2 yr. Elderly patients: Increased risk of adverse reactions. GI effects: Serious GI toxicity (eg, bleeding, ulceration, perforation) can occur at any time with or without warning symptoms. Anaphylactoid reactions: Have occurred in patients with aspirin hypersensitivity and in patients who discontinued tolmetin, then restarted it. Renal impairment: Use drug with caution in patients with compromised cardiac function, hypertension or other conditions predisposing to fluid retention.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Edema; sodium retention; hypertension; CHF. CNS: Dizziness; drowsiness; lightheadedness; confusion; increased sweating; ertigo; headache; nervousness; migraine; anxiety; aggravated Parkinson’s disease or epilepsy; paresthesia; peripheral neuropathy; myalgia; fatigue; sthenia; depression. DERM: Rash; pruritus; urticaria; purpura; erythema multiforme; skin irritation; sweating. EENT: Blurred vision; tinnitus; visual disturbances. GI: Nausea; dyspepsia; abdominal pain or discomfort; flatulence; diarrhea; onstipation; vomiting; gastritis; anorexia; glossitis; stomatitis; mouth ulcers; peptic ulcer; GI distress. GU: Hematuria; proteinuria; dysuria; elevations in BUN; acute renal insufficiency; nterstitial nephritis; hyperkalemia; hyponatremia; renal papillary necrosis; TIs. HEMA: Increased bleeding time; anemia; decreases in Hgb or Hct; leukopenia; hrombocytopenia; hemolytic anemia. HEPA: Hepatitis; increased LFT results; elevated liver enzymes. META: Weight decrease or increase. RESP: Bronchospasm; laryngeal edema; rhinitis; dyspnea; pharyngitis; emoptysis; shortness of breath.

Drug Mode of Action ::  

 Action Decreases inflammation, pain and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.

Drug Interactions ::

 Interactions

Anticoagulants: May increase effect of anticoagulants due to decreased plasma protein binding. May increase risk of gastric erosion and bleeding. Cyclosporine: May potentiate nephrotoxicity of both agents. Methotrexate: May increase methotrexate levels.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Assess renal function before and during therapy, especially in patients with renal impairment.
  • Monitor serum uric acid, serum creatinine and BUN and report if increased.
  • Monitor periodic urine tests for blood and protein and report positive results to physician. Be aware when testing for proteinuria that using sulfosalicylic acid may cause false-positive results. Use dye-impregnated reagent strips.
  • Monitor results of LFTs and report dyscrasias to physician.
  • Monitor serum potassium (report hyperkalemia) and sodium (eport hyponatremia).
  • Monitor Hgb and Hct and notify physician of decrease.
  • Obtain periodic occult blood test in stool if patient is receiving long-term therapy.
  • Monitor BP and I&O throughout therapy.
  • Notify physician of any shortness of breath or other signs of edema.
  • Assess visual acuity and hearing with periodic exams for patients on prolonged therapy, especially if patient experiences blurred vision or changes in color vision.
OVERDOSAGE: SIGNS & SYMPTOMS
  Drowsiness, dizziness, mental confusion, paresthesia, vomiting, abdominal pain, intense headache, tinnitus, sweating, convulsions, visual disturbances, elevated serum creatinine and BUN levels, hypotension

Drug Storage/Management ::

 Administration/Storage

  • Administer capsules or tablets orally tid with schedule including morning dose and evening dose.
  • Do not administer with food, milk or sodium bicarbonate.
  • If GI distress occurs, give with antacids that do not contain sodium bicarbonate.
  • Store at room temperature. Do not expose to sunlight or moisture.

Drug Notes ::

 Patient/Family Education

  • Explain that product should not be taken with aspirin or other NSAIDs without consulting physician.
  • Explain that full antirheumatic action may not occur for up to 7 days and may not reach maximum effect for up to 1 mo after starting therapy.
  • Tell patient to avoid taking with food or milk or immediately after meal. If medication causes stomach upset tell patient to take with antacids that do not contain sodium bicarbonate. Instruct patient to call physician if pain continues.
  • Tell patient to avoid smoking or drinking alcohol while taking this drug.
  • Explain that dizziness or black stools should be reported to physician immediately.
  • Explain that if drowsiness, dizziness or blurred vision occur, patient should observe caution while driving or performing other tasks requiring alertness.
  • Explain that photosensitivity may occur and to use sunscreens and protective clothing when exposed to ultraviolet or sunlight until tolerance is determined.
  • Identify potential clinically important adverse reactions: Drowsiness, blurred vision, edema, headache, lightheadedness, confusion, fatigue, swelling feet, ringing of ears, nausea, vomiting, mouth ulcers, unusual bleeding or bruising, rash, itching or skin irritation. Tell patient to notify physician if persistent or severe.
  • Tell patient not to store drug in bathroom but in cool, dry place.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

Leave a comment

Your email address will not be published. Required fields are marked *

royalmpo Royalmpo Royalmpo royalmpo royalmpo royalmpo royalmpo https://malangtoday.id/ https://guyonanbola.com/ renunganhariankatolik.web.id royalmpo royalmpo royalmpo dewaslot168 ri188 https://hayzlett.com/c-suite-network/ kingslot jkt88 mpodewa https://going-natural.com/the-story-behind-the-mutilated-scalp-video/ royalmpo/ pisang88/ langkahcurang/ mpohoki/ mpocuan/ royalmpo/ mporoyal/ asiaslot/ rajaslot138/ royalmpo https://hayzlett.com/news/ rajaslot88/ Analisis Scatter Hitam MahjongWays RTP Terukur Kemenangan Puluhan Grid Fase Awal Mahjong Pola Perilaku Pemain Harian Prediksi Strategi Game Terbaik RTP Strategi Target Kemenangan Tekanan Meja Live Kasino Slot Digital Hiburan Ringan Slot Online Tanpa Target Mengelola Mood Pemain Slot https://going-natural.com/my-braid-locs/ https://going-natural.com/kellen-marcus/ narutoslot bangslot royalmpo royalmpo macanasia bosslot slotking gacorway
Strategi Analitik Platform Game Dalam Mengelola Variasi Pola Permainan Online Di Era Windows 12 Pendekatan Data Driven Dalam Memahami Ritme Sistem Permainan Digital Pada Ekosistem Android Modern Studi Dinamika Platform Gaming Melalui Distribusi Kombinasi Simbol Di Tengah Popularitas Xbox Game Pass Analisis Strategi Modern Dalam Mengelola Volatilitas Sistem Permainan Digital Saat Tren Nintendo Kembali Naik Framework Pengolahan Data Gaming Untuk Menjaga Stabilitas Pola Permainan Dalam Era Gemini AI Tools Teori Permainan Mahjong Ways Dalam Analisa Intensitas Sistem RTP Online Pada Perangkat Smartphone Modern Pendekatan Sistematis Dalam Menganalisis Pola Permainan Pada Ekosistem Gaming Setelah Discord Down Model Evaluasi Strategi Platform Game Melalui Observasi Pergerakan Algoritma Setelah Update iOS 26.3.1 Strategi Adaptif Dalam Mengelola Ritme Permainan Pada Platform Digital Dengan Dukungan Windows 12 Pendekatan Data Analitik Untuk Mengidentifikasi Pola Sistem Permainan Mobile Pada Samsung Galaxy S26 Ultra
Studi Adaptasi Strategi Permainan Mahjong Dalam Sistem Platform Digital Di Tengah Tren Nintendo Gaming Analisis Teknologi Gaming Platform Dalam Evolusi Sistem Permainan Berbasis RTP Di Era Gemini AI Pendekatan Sistematik Dalam Analisis Algoritma Permainan Mobile Saat Dark Mode Twitter Kembali Trending Studi Pola Mahjong Ways Dalam Perspektif Strategi Platform Game Pada Perangkat Smartphone Modern Analisis Perkembangan Algoritma Platform Gaming Dalam Sistem Permainan Pada Era Xbox Game Pass Pendekatan Manajemen Risiko Permainan Mobile Dalam Ekosistem Gaming Android Generasi Baru Strategi Pengamatan Sistem Permainan Dalam Lingkungan Platform Game Modern Saat Windows 12 Dibahas Evaluasi Sistem Gaming Platform Dalam Mengelola Variasi Pola Permainan Pada Perangkat Samsung Galaxy Framework Analitik Permainan Digital Dalam Mengelola Variasi Sistem Game Saat Re9 Update Dibahas Gamer Studi Dinamika Platform Game Melalui Pendekatan Analisis Data Di Era Apple Newsroom Digital Model Framework Strategi Permainan Digital Dalam Platform Gaming Berbasis Android Modern Strategi Pengelolaan Sistem Permainan Melalui Pendekatan Data Analitik Pada Infrastruktur Cloud Gaming Analisis Adaptasi Sistem Permainan Dalam Ekosistem Gaming Digital Saat Project Helix Menjadi Sorotan Pendekatan Modern Dalam Analisis Pola Permainan Berbasis Data Saat Gemini AI Digunakan Developer Evaluasi Dinamika Sistem Permainan Digital Melalui Observasi Data Pada Sistem iOS 26.3.1 Studi Struktur Sistem Game Dalam Perspektif Teknologi Gaming Di Tengah Tren Nintendo Global Pendekatan Framework Gaming Dalam Mengelola Pola Permainan Digital Di Tengah Popularitas Mario Day Analisis Perubahan Pola Mahjong Wins Dalam Ekosistem Gaming Modern Saat Re9 Update Diperbincangkan Model Analitik Pola Permainan Mahjong Dalam Sistem Platform Digital Modern Berbasis Android Studi Evolusi Teknologi Gaming Dalam Pengembangan Platform Permainan Pada Sistem Windows 12 Strategi Modern Membaca Sistem Permainan Digital Berbasis Algoritma Pada Infrastruktur Cloud Gaming Evaluasi Sistem Platform Game Dalam Dinamika Permainan Online Pada Era Smartphone Modern Pendekatan Data Platform Dalam Mengidentifikasi Pola Permainan Online Pada Infrastruktur TV App Strategi Pengolahan Data Gaming Dalam Mengelola Pola Permainan RTP Pada Infrastruktur Gaming Cloud Strategi Pengelolaan Pola Permainan Melalui Analisis Platform Digital Saat iPhone Generasi Baru Dirilis Pendekatan Analitik Sistem Game Dalam Mengelola Ritme Permainan Pada Era Xbox Game Pass Strategi Data Driven Dalam Menganalisis Pola Sistem Permainan Digital Pada Infrastruktur Cloud Studi Algoritma Permainan Mahjong Dalam Perspektif Platform Gaming Pada Ekosistem Android Analisis Sistem Permainan Digital Dalam Kerangka Strategi Platform Game Di Era Apple Ecosystem Dinamika Sistem Permainan Mahjong Digital Melalui Observasi Ritme Algoritma Pada Ekosistem Gaming Mobile Modern Pola Mahjong Ways 2 Hari Ini Strategi Malam Mahjong Wins 3 Kisah Sukses Andi Grid Mahjong & Starlight Saksi Mata: Mode Manual Mahjong Wins RTP Bertahap Pragmatic Spiral Pola Mahjong Ways Kurikulum Jackpot Respon Mahjong Wins 3 Lebih Cepat Akselerasi Free Spin Mahjong Wins3